AAAAAA

   
Results: 1-25 | 26-27
Results: 1-25/27
SEROUS CARCINOMA OF THE UTERUS TREATED WITH CISPLATIN, DOXORUBICIN AND ETOPOSIDE
Authors: CHAMBERS JT RUTHERFORD TJ BAKER L KOHORN EI SCHWARTZ PE CARCANGIU ML CHAMBERS SK
Citation: Jt. Chambers et al., SEROUS CARCINOMA OF THE UTERUS TREATED WITH CISPLATIN, DOXORUBICIN AND ETOPOSIDE, International journal of gynecological cancer, 8(3), 1998, pp. 193-196
EFFECTIVE TREATMENT OF STAGE-I UTERINE PAPILLARY SEROUS CARCINOMA WITH HIGH-DOSE-RATE VAGINAL APEX RADIATION (IR-192) AND CHEMOTHERAPY
Authors: TURNER BC KNISELY JPS KACINSKI BM HAFFTY BG GUMBS AA ROBERTS KB FRANK AH PESCHEL RE RUTHERFORD TJ EDRAKI B KOHORN EI CHAMBERS SK SCHWARTZ PE WILSON LD
Citation: Bc. Turner et al., EFFECTIVE TREATMENT OF STAGE-I UTERINE PAPILLARY SEROUS CARCINOMA WITH HIGH-DOSE-RATE VAGINAL APEX RADIATION (IR-192) AND CHEMOTHERAPY, International journal of radiation oncology, biology, physics, 40(1), 1998, pp. 77-84
NECROSIS OF MYOMETRIAL CHORIOCARCINOMA WITH FULMINATING SEPSIS COMPLICATING CHEMOTHERAPY FOR TROPHOBLASTIC TUMOR
Authors: ODUNSI KO PECK LL KOHORN EI PARKASH V CRACCHIOLO B CHAMBERS JT TAYLOR KJ
Citation: Ko. Odunsi et al., NECROSIS OF MYOMETRIAL CHORIOCARCINOMA WITH FULMINATING SEPSIS COMPLICATING CHEMOTHERAPY FOR TROPHOBLASTIC TUMOR, Gynecologic oncology (Print), 70(1), 1998, pp. 100-104
UNTITLED
Authors: KOHORN EI
Citation: Ei. Kohorn, UNTITLED, Gynecologic oncology, 68(2), 1998, pp. 214-214
NONMETASTATIC GESTATIONAL TROPHOBLASTIC NEOPLASIA - ROLE OF ULTRASONOGRAPHY AND MAGNETIC-RESONANCE-IMAGING
Authors: KOHORN EI MCCARTHY SM TAYLOR KJW
Citation: Ei. Kohorn et al., NONMETASTATIC GESTATIONAL TROPHOBLASTIC NEOPLASIA - ROLE OF ULTRASONOGRAPHY AND MAGNETIC-RESONANCE-IMAGING, Journal of reproductive medicine, 43(1), 1998, pp. 14-20
STAGING AND ASSESSING TROPHOBLASTIC TUMORS - A POSSIBLE SOLUTION TO AN INTRACTABLE PROBLEM
Authors: KOHORN EI
Citation: Ei. Kohorn, STAGING AND ASSESSING TROPHOBLASTIC TUMORS - A POSSIBLE SOLUTION TO AN INTRACTABLE PROBLEM, Journal of reproductive medicine, 43(1), 1998, pp. 33-36
CA-125 MAY NOT REFLECT DISEASE STATUS IN PATIENTS WITH UTERINE SEROUSCARCINOMA
Authors: PRICE FV CHAMBERS SK CARCANGIU ML KOHORN EI SCHWARTZ PE CHAMBERS JT
Citation: Fv. Price et al., CA-125 MAY NOT REFLECT DISEASE STATUS IN PATIENTS WITH UTERINE SEROUSCARCINOMA, Cancer, 82(9), 1998, pp. 1720-1725
PHARMACOKINETIC AND PHASE-I TRIAL OF INTRAPERITONEAL CARBOPLATIN AND CYCLOSPORINE IN REFRACTORY OVARIAN-CANCER PATIENTS
Authors: CHAMBERS SK CHAMBERS JT DAVIS CA KOHORN EI SCHWARTZ PE LORBER MI HANDSCHUMACHER RE PIZZORNO G
Citation: Sk. Chambers et al., PHARMACOKINETIC AND PHASE-I TRIAL OF INTRAPERITONEAL CARBOPLATIN AND CYCLOSPORINE IN REFRACTORY OVARIAN-CANCER PATIENTS, Journal of clinical oncology, 15(5), 1997, pp. 1945-1952
MODULATION OF PLATINUM SENSITIVITY AND RESISTANCE BY CYCLOSPORINE-A IN REFRACTORY OVARIAN AND FALLOPIAN-TUBE CANCER-PATIENTS - A PHASE-II STUDY
Authors: CHAMBERS SK DAVIS CA SCHWARTZ PE KOHORN EI CHAMBERS JT
Citation: Sk. Chambers et al., MODULATION OF PLATINUM SENSITIVITY AND RESISTANCE BY CYCLOSPORINE-A IN REFRACTORY OVARIAN AND FALLOPIAN-TUBE CANCER-PATIENTS - A PHASE-II STUDY, Clinical cancer research, 2(10), 1996, pp. 1693-1697
DECISION-MAKING FOR CHEMOTHERAPY ADMINISTRATION IN PATIENTS WITH LOW-RISK GESTATIONAL TROPHOBLASTIC NEOPLASIA
Authors: KOHORN EI
Citation: Ei. Kohorn, DECISION-MAKING FOR CHEMOTHERAPY ADMINISTRATION IN PATIENTS WITH LOW-RISK GESTATIONAL TROPHOBLASTIC NEOPLASIA, International journal of gynecological cancer, 6(4), 1996, pp. 279-285
IS MAGNETIC-RESONANCE-IMAGING A USEFUL AID IN CONFIRMING THE DIAGNOSIS OF NONMETASTATIC GESTATIONAL TROPHOBLASTIC NEOPLASIA
Authors: KOHORN EI MCCARTHY SM BARTON JW
Citation: Ei. Kohorn et al., IS MAGNETIC-RESONANCE-IMAGING A USEFUL AID IN CONFIRMING THE DIAGNOSIS OF NONMETASTATIC GESTATIONAL TROPHOBLASTIC NEOPLASIA, International journal of gynecological cancer, 6(2), 1996, pp. 128-134
COMBINATION CHEMOTHERAPY WITH ETOPOSIDE, CISPLATIN, AND DOXORUBICIN IN MIXED MULLERIAN TUMORS OF THE ADNEXA
Authors: CASS I RESNIK E CHAMBERS JT CHAMBERS SK CARCANGIU ML KOHORN EI SCHWARTZ PE
Citation: I. Cass et al., COMBINATION CHEMOTHERAPY WITH ETOPOSIDE, CISPLATIN, AND DOXORUBICIN IN MIXED MULLERIAN TUMORS OF THE ADNEXA, Gynecologic oncology, 61(3), 1996, pp. 309-314
RADIATION-THERAPY AS EXCLUSIVE TREATMENT FOR MEDICALLY INOPERABLE PATIENTS WITH STAGE-I AND STAGE-II ENDOMETRIOID CARCINOMA OF THE ENDOMETRIUM
Authors: FISHMAN DA ROBERTS KB CHAMBERS JT KOHORN EI SCHWARTZ PE CHAMBERS SK
Citation: Da. Fishman et al., RADIATION-THERAPY AS EXCLUSIVE TREATMENT FOR MEDICALLY INOPERABLE PATIENTS WITH STAGE-I AND STAGE-II ENDOMETRIOID CARCINOMA OF THE ENDOMETRIUM, Gynecologic oncology, 61(2), 1996, pp. 189-196
UTERINE PAPILLARY SEROUS CARCINOMA TREATED WITH INTRAPERITONEAL CISPLATIN AND INTRAVENOUS DOXORUBICIN AND CYCLOPHOSPHAMIDE
Authors: CHAMBERS JT CHAMBERS SK KOHORN EI CARCANGIU ML SCHWARTZ PE
Citation: Jt. Chambers et al., UTERINE PAPILLARY SEROUS CARCINOMA TREATED WITH INTRAPERITONEAL CISPLATIN AND INTRAVENOUS DOXORUBICIN AND CYCLOPHOSPHAMIDE, Gynecologic oncology, 60(3), 1996, pp. 438-442
MALIGNANT UTERINE SMOOTH-MUSCLE TUMORS - ROLE OF ETOPOSIDE, CISPLATIN, AND DOXORUBICIN (EPA) CHEMOTHERAPY
Authors: RESNIK E CHAMBERS SK CARCANGIU ML KOHORN EI SCHWARTZ PE CHAMBERS JT
Citation: E. Resnik et al., MALIGNANT UTERINE SMOOTH-MUSCLE TUMORS - ROLE OF ETOPOSIDE, CISPLATIN, AND DOXORUBICIN (EPA) CHEMOTHERAPY, Journal of surgical oncology, 63(3), 1996, pp. 145-147
FOR WHAT WE STAND - PRESIDENTIAL-ADDRESS
Authors: KOHORN EI
Citation: Ei. Kohorn, FOR WHAT WE STAND - PRESIDENTIAL-ADDRESS, American journal of obstetrics and gynecology, 175(6), 1996, pp. 1414-1417
PANNICULECTOMY AS AN INTEGRAL-PART OF PELVIC OPERATION IS AN UNDERUTILIZED TECHNIQUE IN PATIENTS WITH MORBID-OBESITY
Authors: KOHORN EI
Citation: Ei. Kohorn, PANNICULECTOMY AS AN INTEGRAL-PART OF PELVIC OPERATION IS AN UNDERUTILIZED TECHNIQUE IN PATIENTS WITH MORBID-OBESITY, Journal of the American College of Surgeons, 180(3), 1995, pp. 279-285
A PHASE-II STUDY OF ETOPOSIDE, CISPLATIN, AND DOXORUBICIN CHEMOTHERAPY IN MIXED MULLERIAN TUMORS (MMT) OF THE UTERUS
Authors: RESNIK E CHAMBERS SK CARCANGIU ML KOHORN EI SCHWARTZ PE CHAMBERS JT
Citation: E. Resnik et al., A PHASE-II STUDY OF ETOPOSIDE, CISPLATIN, AND DOXORUBICIN CHEMOTHERAPY IN MIXED MULLERIAN TUMORS (MMT) OF THE UTERUS, Gynecologic oncology, 56(3), 1995, pp. 370-375
EXTRAMAMMARY PAGETS-DISEASE OF THE VULVA
Authors: FISHMAN DA CHAMBERS SK SCHWARTZ PE KOHORN EI CHAMBERS JT
Citation: Da. Fishman et al., EXTRAMAMMARY PAGETS-DISEASE OF THE VULVA, Gynecologic oncology, 56(2), 1995, pp. 266-270
THE TROPHOBLASTIC TOWER-OF-BABEL - CLASSIFICATION SYSTEMS FOR METASTATIC GESTATIONAL TROPHOBLASTIC NEOPLASIA
Authors: KOHORN EI
Citation: Ei. Kohorn, THE TROPHOBLASTIC TOWER-OF-BABEL - CLASSIFICATION SYSTEMS FOR METASTATIC GESTATIONAL TROPHOBLASTIC NEOPLASIA, Gynecologic oncology, 56(2), 1995, pp. 280-288
MACROPHAGE-COLONY-STIMULATING FACTOR-1, A CLINICALLY USEFUL TUMOR-MARKER IN ENDOMETRIAL ADENOCARCINOMA - COMPARISON WITH CA-125 AND THE AMINOTERMINAL PROPEPTIDE OF TYPE-III PROCOLLAGEN
Authors: HAKALA A KACINSKI BM STANLEY ER KOHORN EI PUISTOLA U RISTELI J RISTELI L TOMAS C KAUPPILA A
Citation: A. Hakala et al., MACROPHAGE-COLONY-STIMULATING FACTOR-1, A CLINICALLY USEFUL TUMOR-MARKER IN ENDOMETRIAL ADENOCARCINOMA - COMPARISON WITH CA-125 AND THE AMINOTERMINAL PROPEPTIDE OF TYPE-III PROCOLLAGEN, American journal of obstetrics and gynecology, 173(1), 1995, pp. 112-119
CHEMOTHERAPY OF RECURRENT ADVANCED CERVICAL-CANCER - RESULTS OF THE YALE-UNIVERSITY PBM PFU PROTOCOL
Authors: CHAMBERS SK LAMB L KOHORN EI SCHWARTZ PE CHAMBERS JT
Citation: Sk. Chambers et al., CHEMOTHERAPY OF RECURRENT ADVANCED CERVICAL-CANCER - RESULTS OF THE YALE-UNIVERSITY PBM PFU PROTOCOL, Gynecologic oncology, 53(2), 1994, pp. 161-169
DETECTING AND MONITORING TROPHOBLASTIC DISEASE - NEW PERSPECTIVES ON MEASURING HUMAN CHORIONIC-GONADOTROPIN LEVELS
Authors: COLE LA KOHORN EI KIM GS
Citation: La. Cole et al., DETECTING AND MONITORING TROPHOBLASTIC DISEASE - NEW PERSPECTIVES ON MEASURING HUMAN CHORIONIC-GONADOTROPIN LEVELS, Journal of reproductive medicine, 39(3), 1994, pp. 193-200
PROGNOSTIC INDICATORS FOR POOR-RISK EPITHELIAL OVARIAN-CARCINOMA
Authors: ROSMAN M HAYDEN CL THIEL RP CHAMBERS JT KOHORN EI CHAMBERS SK SCHWARTZ PE
Citation: M. Rosman et al., PROGNOSTIC INDICATORS FOR POOR-RISK EPITHELIAL OVARIAN-CARCINOMA, Cancer, 74(4), 1994, pp. 1323-1328
INTRAVENOUS CISPLATIN, DOXORUBICIN, AND CYCLOPHOSPHAMIDE IN THE TREATMENT OF UTERINE PAPILLARY SEROUS CARCINOMA (UPSC)
Authors: PRICE FV CHAMBERS SK CARCANGIU ML KOHORN EI SCHWARTZ PE CHAMBERS JT
Citation: Fv. Price et al., INTRAVENOUS CISPLATIN, DOXORUBICIN, AND CYCLOPHOSPHAMIDE IN THE TREATMENT OF UTERINE PAPILLARY SEROUS CARCINOMA (UPSC), Gynecologic oncology, 51(3), 1993, pp. 383-389
Risultati: 1-25 | 26-27